
3-bromo-5-phenyl Salicylic AcidAKR1C1 inhibitor |
Sample solution is provided at 25 µL, 10mM.
































Quality Control & MSDS
- View current batch:
- Purity ≥ 95.00%
- COA (Certificate Of Analysis)
- MSDS (Material Safety Data Sheet)
Chemical structure


3-bromo-5-phenyl Salicylic Acid Dilution Calculator
calculate

3-bromo-5-phenyl Salicylic Acid Molarity Calculator
calculate
Cas No. | 4906-68-7 | SDF | Download SDF |
Synonyms | NSC 109116 | ||
Chemical Name | 5-bromo-4-hydroxy-[1,1"-biphenyl]-3-carboxylic acid | ||
Canonical SMILES | BrC1=CC(C2=CC=CC=C2)=CC(C(O)=O)=C1O | ||
Formula | C13H9BrO3 | M.Wt | 293.1 |
Solubility | ≤0.1mg/ml in ethanol;12.5mg/ml in DMSO;15mg/ml in dimethyl formamide | Storage | Store at -20°C |
Physical Appearance | A crystalline solid | Shipping Condition | Evaluation sample solution : ship with blue ice.All other available size:ship with RT , or blue ice upon request |
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. |
Ki: 140 nM for AKR1C1; 1.97 μM for AKR1C2; 21 μM for AKR1C3
3-bromo-5-phenyl Salicylic acid is an AKR1C1 inhibitor.
The aldo-keto reductase (AKR) enzymes are a family of related NADP-dependent oxidoreductases, in which The 1C subfamily (AKR1C) has 4 human hydroxysteroid dehydrogenases (HSD), a 20α-HSD and the other three being 3α-HSDs. AKR1C1 has been found to metabolize progesterone to 20α-hydroxy progesterone, its inactive progestin.
In vitro: In previous screening study, the additional phenyl group of 3-bromo-5-phenylsalicylic acid, targeting a nonconserved hydrophobic pocket in the active site of AKR1C1, resulted in 21-fold improved potency over the structurally similar 3alpha-hydroxysteroid dehydrogenase isoform (AKR1C2). 3-bromo-5-phenyl Salicylic acid was found to be hydrogen bonded to His117, Tyr55, and His222, and the phenyl ring could form additional van der Waals interactions with residues Phe311, Leu308, and Leu54. In addition, the metabolism of progesterone in AKR1C1-overexpressed cells could be potently inhibited by 3-bromo-5-phenylsalicylic acid, which was effective from 10 nM to 460 nM [1].
In vivo: Up to now, there is no animal in vivo data reported.
Clinical trial: So far, no clinical study has been conducted.
Reference:[1] El-Kabbani, O. ,Scammells, P.J.,Gosling, J., et al. Structure-guided design, synthesis, and evaluation of salicylic acid-based inhibitors targeting a selectivity pocket in the active site of human 20α-hydroxysteroid dehydrogenase (AKR1C1). Journal of Medicinal Chemistry 52, 3259-3264 (2009).
ebiomall.com






>
>
>
>
>
>
>
>
>
>
>
>
配后是否应该分装,因为不能反复冻融?
多谢!
1、发帖请归入相应子版(选择SubBoard)!
2、请在帖子前面注明帖子性质,如【求助】、【原创】、【分享】、【讨论】、【申请上传】、【下载】、【转帖】、【转载】、【信息】、【求购】、【公告】、【建议】等,以方便战友应助及版面管理!
3、不规范的发帖及应助帖将不加分!
4、对于得分在5分以下或贴子数少于20的战友的不规范发贴,第一次我们将帮助修改同时给予提示;对于5分以上或贴子数大于20的战友的不规范发贴将直接锁贴,等待修改(可PM版主),保留24h仍然不修改,将删除所发的贴子而且不另外通知!
【】可以这样输入,智能ABC,输入“v1”,后翻3页,就可以看见了,或用紫光拼音中文输入法,输入方括号就是粗体的中括号,实在不行请复制本公告中【】
我做的双酶切反应,酶分别是宝生物的BamHI和XhoI,双酶切体系是:载体及目的片段分别是30ul,通用buffer4ul,XhoI、BamHI各2ul,无核酶水2ul,总体积40ul。载体和目的片段都是经37度酶切6h。载体上面这两个酶切位点的距离是6个碱基,目的片段是由pcr反应获得的,从puc19中p出来的,两端带有这两种酶的酶切位点,酶切完成后,做连接反应,体系如下:目的片段(全长1441bp)4ul,无核酶水3ul,10*T4DNA连接酶缓冲液1ul,载体1ul,T4DNA连接酶1ul,总体积10ul。16度过夜。之后摇菌送沉菌测序结果回来,送了5管一个都不对。重复实验两次还是不对!
之后改为先用BanHI单切载体,体系如下:载体17ul,酶1ul,buffer2ul,总体积20ul,30度切6小时后,Promega纯化试剂盒直接纯化,完了之后再用XhoI,37度酶切6小时,体系如上,再次用promega纯化试剂盒纯化,目的片段用双酶切体系酶切,之后做连接反应,之后铺板,挑取菌落共10个,摇菌13小时,取菌液做pcr鉴定,结果10个菌落全是引物2聚体,跑出来的条带都是100bp左右。
各位老师这是怎么回事呢?为什么连接不上呢?小弟先谢过各位大哥了!
求问酶切体系为10ul,内切酶1ul,37℃水浴45min,不知道DNA产物是否完全被切开了?
所用内切酶信息如下
同一管dna有的酶可以切开,比如dra1,ecoR1,Hind111
有的酶又完全不能切动,如BamH1,sac1,xba1,xho1,pst1
请问高手这是什么原因??
感谢赐教~!

